Cargando…
Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC
Anticancer drug resistance is a major challenge of cancer therapy. We found that irinotecan-resistant NSCLC cells showed increased mitochondrial oxidative phosphorylation compared to the drug sensitive NSCLC cells. Previously, we found that combined inhibition of aldehyde dehydrogenase using gossypo...
Autores principales: | Lee, Soohyun, Lee, Jae-Seon, Seo, Jinho, Lee, Seon-Hyeong, Kang, Joon Hee, Song, Jaewhan, Kim, Soo-Youl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200737/ https://www.ncbi.nlm.nih.gov/pubmed/30356107 http://dx.doi.org/10.1038/s41598-018-33667-6 |
Ejemplares similares
-
Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling
por: Lee, Jae-Seon, et al.
Publicado: (2020) -
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
por: Lee, Jae-Seon, et al.
Publicado: (2016) -
Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition
por: Lee, Seon-Hyeong, et al.
Publicado: (2018) -
Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation
por: Lee, Jae-Seon, et al.
Publicado: (2019) -
Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation
por: Lee, Jae-Seon, et al.
Publicado: (2019)